Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. digesting enzyme
Show results for
Products
Services
Applications

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Digesting Enzyme Articles & Analysis

16 news found

Alfa Chemistry Integrates Its Supply of Dietary Supplement Ingredients   

Alfa Chemistry Integrates Its Supply of Dietary Supplement Ingredients  

Recognizing the importance of digestive health in overall well-being, Alfa Chemistry also provides a range of health digestion aids to support optimal digestive function. These include probiotics, prebiotics, digestive enzymes, and fiber supplements. By offering these ingredients, Alfa Chemistry aims to help ...

ByAlfa Chemistry


Kidney and Pancreas Function Diagnostic Enzymes Are Now Available at Creative Enzymes

Kidney and Pancreas Function Diagnostic Enzymes Are Now Available at Creative Enzymes

Creative Enzymes, a global leader in diagnostic enzyme manufacturing and supply, is dedicated to offering a wide range of enzyme products as well as customized enzyme-related services for medical and research diagnosis. ...

ByCreative Enzymes


Profacgen Provides Protein Ubiquitination Services to Accelerate Drug Development Project

Profacgen Provides Protein Ubiquitination Services to Accelerate Drug Development Project

Ubiquitin identification and quantification by proteomics analysis Profacgen offers ubiquitin identification and quantification services for protein in cells or tissues. The work starts from enzymes digestion, peptides enrichment, mass spectrometry analysis and bioinformatics analysis. ...

ByProfacgen


Palisade Bio Announces Inducement Awards Under Inducement Plan For Key New Hires

Palisade Bio Announces Inducement Awards Under Inducement Plan For Key New Hires

About Palisade Bio Palisade Bio is a clinical stage biopharmaceutical company advancing therapies that aim to aid patients suffering with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio’s lead asset, LB1148, advancing toward Phase 3, is a protease inhibitor with the potential to both ...

ByPalisade Bio


Palisade Bio Announces $2.0 Million Registered Direct Offering

Palisade Bio Announces $2.0 Million Registered Direct Offering

Palisade Bio is a clinical stage biopharmaceutical company advancing therapies that aid patients suffering with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio’s lead asset LB1148, advancing toward Phase 3, is a protease inhibitor with the potential to both reduce abdominal adhesions and ...

ByPalisade Bio


Palisade Bio And Newsoara Receive NMPA Clearance To Commence Phase 3 Clinical Trial In China Evaluating LB1148 To Accelerate The Return Of Bowel Function Following Abdominal Surgery

Palisade Bio And Newsoara Receive NMPA Clearance To Commence Phase 3 Clinical Trial In China Evaluating LB1148 To Accelerate The Return Of Bowel Function Following Abdominal Surgery

About LB1148 LB1148 is a novel oral liquid formulation of the well-characterized digestive enzyme inhibitor, tranexamic acid (“TXA”), with potential to both reduce abdominal adhesions and help restore bowel function following surgery. ...

ByPalisade Bio


Palisade Bio (Nasdaq: PALI) To Participate In The Virtual Investor Management And KOL Roundtable Event

Palisade Bio (Nasdaq: PALI) To Participate In The Virtual Investor Management And KOL Roundtable Event

About LB1148 LB1148 is a novel oral liquid formulation of the well-characterized digestive enzyme inhibitor, tranexamic acid (“TXA”), with potential to both reduce abdominal adhesions and help restore bowel function following surgery. ...

ByPalisade Bio


Palisade Bio (Nasdaq: PALI) To Participate In The 2022 Virtual Growth Conference Presented By Maxim Group And Hosted By M-Vest

Palisade Bio (Nasdaq: PALI) To Participate In The 2022 Virtual Growth Conference Presented By Maxim Group And Hosted By M-Vest

Click Here to Reserve your seat About Palisade Bio Palisade Bio is a clinical stage biopharmaceutical company advancing therapies that aid patients suffering with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio’s innovative lead asset LB1148, is a protease inhibitor with the potential to ...

ByPalisade Bio


Palisade Bio (Nasdaq: PALI) Announces Analysis Demonstrating LB1148 Reduced The Extent And Severity Of Post-Surgical Intraabdominal Adhesions By 93%

Palisade Bio (Nasdaq: PALI) Announces Analysis Demonstrating LB1148 Reduced The Extent And Severity Of Post-Surgical Intraabdominal Adhesions By 93%

Please click the link below to register for the webcast: https://us06web.zoom.us/webinar/register/WN_ThNZHlT4Q9mBMGrMlxabkg About LB1148 LB1148 is an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. Evidence suggests that the release of ...

ByPalisade Bio


Palisade Bio (Nasdaq: PALI) To Present New Clinical Data Of LB1148 For Preventing Adhesions In Conjunction With Next Big Thing Session At Society Of American Gastrointestinal And Endoscopic Surgeons 2022 Annual Meeting

Palisade Bio (Nasdaq: PALI) To Present New Clinical Data Of LB1148 For Preventing Adhesions In Conjunction With Next Big Thing Session At Society Of American Gastrointestinal And Endoscopic Surgeons 2022 Annual Meeting

Please click the link below to register for the webcast: https://us06web.zoom.us/webinar/register/WN_ThNZHlT4Q9mBMGrMlxabkg About LB1148 LB1148 is an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. Evidence suggests that the release of ...

ByPalisade Bio


Palisade Bio (NASDAQ: PALI) Adds Pharmaceutical Industry Executive Robert McRae To Leadership Team

Palisade Bio (NASDAQ: PALI) Adds Pharmaceutical Industry Executive Robert McRae To Leadership Team

Palisade Bio is a clinical stage biopharmaceutical company advancing therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio’s innovative lead asset LB1148, advancing towards Phase 3, is a protease inhibitor with the potential to both reduce abdominal adhesions and ...

ByPalisade Bio


Palisade Bio To Present At The H.C. Wainwright BIOCONNECT Virtual Conference And Biotech Showcase

Palisade Bio To Present At The H.C. Wainwright BIOCONNECT Virtual Conference And Biotech Showcase

About Palisade Bio Palisade Bio is a clinical stage biopharmaceutical company advancing therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio’s innovative lead asset LB1148, advancing towards Phase 3, is a protease inhibitor with the potential to both reduce ...

ByPalisade Bio


Microalgae Yougurt

Microalgae Yougurt

Probiotics are beneficial forms of gut bacteria that help stimulate the natural digestive juices and enzymes that keep our digestive organs functioning properly. Microalgae are probiotic foods that have been shown to increase the amount of both Lactobacillus and bifidobacteria in the digestive tract. In addition to detoxify ...

ByNecton SA


Creative Enzymes Upgrades Multiple Diagnostic Enzyme Products for Clinical and Diagnostic Research

Creative Enzymes Upgrades Multiple Diagnostic Enzyme Products for Clinical and Diagnostic Research

Creative Enzymes, the world’s leading diagnostic enzyme production company, has been committed to providing customers with various enzyme products and services for medical and research diagnosis. ...

ByCreative Enzymes


Israeli Startup Wants to Cure Diabetes by Making Micro-pancreases. It Worked on Mice

Israeli Startup Wants to Cure Diabetes by Making Micro-pancreases. It Worked on Mice

For one thing, as Mitrani explained to Haaretz, 95% of the tissue in our pancreases is involved in producing digestive enzymes, not insulin regulation. For another, the lung tissue with its enormous surface area proved most compatible. ...

ByBetalin Therapeutics Ltd.


NREL Finds a New Cellulose Digestion Mechanism by a Fast-eating Enzyme

NREL Finds a New Cellulose Digestion Mechanism by a Fast-eating Enzyme

Researchers at the Energy Department’s National Renewable Energy Laboratory (NREL) have discovered that an enzyme from a microorganism first found in the Valley of Geysers on the Kamchatka Peninsula in Russia in 1990 can digest cellulose almost twice as fast as the current leading component cellulase enzyme on the market. ...

ByNational Renewable Energy Laboratory (NREL)

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT